Literature DB >> 12716435

Hypoxia induces de-stabilization of the LAT1 large neutral amino acid transporter mRNA in brain capillary endothelial cells.

Ruben J Boado1, Jian Yi Li, Haruhisa Tsukamoto, William M Pardridge.   

Abstract

Blood-brain barrier (BBB) transport of large neutral amino acids is mediated by the large neutral amino acid transporter type 1 (LAT1 transporter). Although the gene encoding the Glut1 glucose transporter is up-regulated in hypoxia, the response of the LAT1 gene to hypoxia is not known. The present study investigates the changes in the LAT1 mRNA in cultured bovine brain capillary endothelial cells exposed to 1% O2 for 24-48 h. The LAT1 mRNA was initially down-regulated in hypoxia with reciprocal changes in the Glut1 mRNA. No changes in the 4F2hc mRNA in hypoxia were observed. Hypoxia caused an initial de-stabilization of the LAT1 mRNA, and the t1/2 of the LAT1 mRNA in control and hypoxic cells was 6.4 +/- 0.5 and 2.4 +/- 0.1 h, respectively. To further explore post-transcriptional regulation of LAT1 gene expression, the polysome and cytosol fractions of the control and hypoxic endothelial cells were isolated, and LAT1 mRNA binding proteins were detected by ultraviolet light cross-linking. Whereas the cytosol contained no LAT1 mRNA binding proteins, the cell polysome fraction expressed several LAT1 mRNA binding proteins, including principal 40-, 70- and 80-kDa proteins. These studies are consistent with post-transcriptional de-stabilization of the LAT1 large neutral amino acid transporter in hypoxia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716435     DOI: 10.1046/j.1471-4159.2003.01757.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

2.  LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer.

Authors:  Kyoichi Kaira; Noboru Oriuchi; Toshiaki Takahashi; Kazuo Nakagawa; Yasuhisa Ohde; Takehiro Okumura; Haruyasu Murakami; Takehito Shukuya; Hirotsugu Kenmotsu; Tateaki Naito; Yoshikatsu Kanai; Masahiro Endo; Haruhiko Kondo; Takashi Nakajima; Nobuyuki Yamamoto
Journal:  Am J Transl Res       Date:  2011-10-07       Impact factor: 4.060

Review 3.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

4.  Blood-brain barrier genomics and cloning of a novel organic anion transporter.

Authors:  Chun Chu; Jian Yi Li; Ruben J Boado; William M Pardridge
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-01       Impact factor: 6.200

5.  The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.

Authors:  Ryan S Youland; Gaspar J Kitange; Timothy E Peterson; Deanna H Pafundi; Judi A Ramiscal; Jenny L Pokorny; Caterina Giannini; Nadia N Laack; Ian F Parney; Val J Lowe; Debra H Brinkmann; Jann N Sarkaria
Journal:  J Neurooncol       Date:  2012-10-20       Impact factor: 4.130

Review 6.  The Neurovascular Unit: Effects of Brain Insults During the Perinatal Period.

Authors:  Alexander H Bell; Suzanne L Miller; Margie Castillo-Melendez; Atul Malhotra
Journal:  Front Neurosci       Date:  2020-01-22       Impact factor: 4.677

7.  Hypoxia increases expression of selected blood-brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers.

Authors:  Burak Ozgür; Hans Christian Cederberg Helms; Erica Tornabene; Birger Brodin
Journal:  Fluids Barriers CNS       Date:  2022-01-04

Review 8.  Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer.

Authors:  Danushka Seneviratne; Pooja Advani; Daniel M Trifiletti; Saranya Chumsri; Chris J Beltran; Aaron F Bush; Laura A Vallow
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.